Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Samir Gupta, Simon Couillard, Geneviève Digby, Sze Man Tse, Samantha Green, Raymond Aceron, Chris Carlsten, Jill Hubick & Erika Penz. (2023) Canadian Thoracic Society Position Statement on Climate Change and Choice of Inhalers for Patients with Respiratory Disease. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 7:5, pages 232-239.
Read now
Read now
Varsha Komalla, Chun Yuen Jerry Wong, Imco Sibum, Bernhard Muellinger, Wietze Nijdam, Vishal Chaugule, Julio Soria, Hui Xin Ong, Nicolas A. Buchmann & D. Traini. (2023) Advances in soft mist inhalers. Expert Opinion on Drug Delivery 20:8, pages 1055-1070.
Read now
Read now
Yi-Han Hsiao, Ching-Min Tseng, Chau-Chyun Sheu, Hsin-Yi Wang, Hsin-Kuo Ko, Kang-Cheng Su, Chi-Wei Tao, Ming-Ju Tsai & Yen-Fu Chen. (2022) Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2067-2078.
Read now
Read now
Arschang Valipour, Sergey Avdeev, Adam Barczyk, Valentina Bayer, Zvi Fridlender, Mariela Georgieva, Ondřej Kudela, Alexey Medvedchikov, Ramona Miron, Maria Sanzharovskaya, Virginija Šileikienė, Jurij Šorli, Marc Spielmanns & Zsuzsanna Szalai. (2021) Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 615-628.
Read now
Read now
Ethan Karle, Tarang P. Patel, Jason Zweig & Armin Krvavac. (2020) Understanding the Knowledge Gap and Assessing Comfort Level among Healthcare Professionals Who Provide Inhaler Education. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 197-204.
Read now
Read now
Christian Vogelberg. (2019) Anticholinergics in asthma: are we utilizing asthma therapies effectively?. Therapeutics and Clinical Risk Management 15, pages 405-408.
Read now
Read now
Omar S Usmani. (2019) Choosing the right inhaler for your asthma or COPD patient. Therapeutics and Clinical Risk Management 15, pages 461-472.
Read now
Read now
Karl-Otto Steinmetz, Birgit Abenhardt, Stefan Pabst, Michaela Hänsel, Anke Kondla, Valentina Bayer & Roland Buhl. (2019) Assessment of physical functioning and handling of tiotropium/olodaterol Respimat® in patients with COPD in a real-world clinical setting. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1441-1453.
Read now
Read now
Christos Chouaid, Nicola Germain, Gérard De Pouvourville, Samuel Aballéa, Daria Korchagina, Michael Baldwin, Katell Le Lay, Laura Luciani, Mondher Toumi & Philippe Devillier. (2019) Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Current Medical Research and Opinion 35:5, pages 785-792.
Read now
Read now
Gary T. Ferguson & Richard N. Dalby. (2018) Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease. Postgraduate Medicine 130:6, pages 515-522.
Read now
Read now
Chi-Yen Liang, Yi-Jen Chen, Shew-Meei Sheu, Ching-Fang Tsai & Wei Chen. (2018) Misuse of inhalers among COPD patients in a community hospital in Taiwan. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1309-1316.
Read now
Read now
Bo Ding, Mark Small, Gina Scheffel & Ulf Holmgren. (2018) Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma–COPD overlap syndrome consulting for routine care. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 927-936.
Read now
Read now
Maria Iordanidou, Stelios Loukides & Emmanouil Paraskakis. (2017) Asthma phenotypes in children and stratified pharmacological treatment regimens. Expert Review of Clinical Pharmacology 10:3, pages 293-303.
Read now
Read now
Articles from other publishers (29)
David M. G. Halpin & Donald A. Mahler. (2022) A Systematic Review of Published Algorithms for Selecting an Inhaled Delivery System in Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 19:7, pages 1213-1220.
Crossref
Crossref
Liansheng Zhang, Xiaoqing Wang, Ye Zhang & Wenyu Chen. (2022) Efficacy and Safety of Single Inhaler Triple Therapy Versus Separate Triple Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Clinical Therapeutics 44:6, pages 859-873.
Crossref
Crossref
Zia Ul Mustafa, Muhammad Salman, Irsa Jamal, Mahpara Kanwal, Muhammad Bilal Riaz, Syed Shahzad Hasan & Amer Hayat Khan. (2022) A pharmacist-led educational intervention to improve nebulization-related knowledge and practices of nursing staff: a pre–post interventional study from Pakistan. Drugs & Therapy Perspectives 38:4, pages 194-200.
Crossref
Crossref
M. Matuszak, M. Ochowiak, S. Włodarczak, A. Krupińska & M. Doligalski. (2022) State-of-the-art review of the application and development of various methods of aerosol therapy. International Journal of Pharmaceutics 614, pages 121432.
Crossref
Crossref
R. de Simón Gutiérrez, L. Ginel Mendoza, A. Hidalgo Requena, D. Rico Munilla & F. Cantalapiedra Fernández. (2022) ¿Desechan correctamente los pacientes sus dispositivos de inhalación? Proyecto AIRE. Medicina de Familia. SEMERGEN 48:1, pages 14-22.
Crossref
Crossref
Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics
1
46
.
Omar S Usmani. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
754
765
.
Paschalis Steiropoulos, Petros Bakakos, Elpis Hatziagorou, Paraskevi Katsaounou, Stelios Loukides, Andriana Papaioannou, Konstantinos Porpodis, Konstantinos Samaras, Argyrios Tzouvelekis, Konstantinos Kalafatakis & Konstantinos Kostikas. (2021) The present and future of inhalation therapy for
the management of obstructive airway diseases:
Emphasis on pressurized metered-dose inhalers. Pneumon, pages 1-13.
Crossref
Crossref
Yingmin Liang & Judith C.W. Mak. (2021) Inhaled Therapies for Asthma and Chronic Obstructive Pulmonary Disease. Current Pharmaceutical Design 27:12, pages 1469-1481.
Crossref
Crossref
Michael Dreher, David Price, Asparuh Gardev, Pascale Peeters, Satish Arora, Simone van der Sar – van der Brugge, Richard Dekhuijzen & Omar S Usmani. (2021)
Patient perceptions of the re-usable Respimat
®
Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
. Chronic Respiratory Disease 18, pages 147997312098622.
Crossref
Crossref
Gustaf Ortsäter, Fredrik Borgström, Mike Baldwin & Carolin Miltenburger. (2019) Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable Inhaler. Applied Health Economics and Health Policy 18:3, pages 433-442.
Crossref
Crossref
Duncan Keeley, Jane E. Scullion & Omar S. Usmani. (2020) Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers. European Respiratory Journal 55:5, pages 2001122.
Crossref
Crossref
F. Lavorini, A. Bianco, F. Blasi, F. Braido, A.G. Corsico, F. Di Marco, A. Gentile, P.L. Paggiaro, V. Pegoraro, G. Pelaia, P. Rogliani, P. Santus, N. Scichilone, A. Soldi & G.W. Canonica. (2020) What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis. Respiratory Medicine 166, pages 105937.
Crossref
Crossref
Duncan Keeley, Jane E. Scullion & Omar S. Usmani. (2020) Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers. European Respiratory Journal 55:2, pages 2000048.
Crossref
Crossref
Junhua Hu, Xi Chen, Sixu Li, Xiaojie Zheng, Rui Zhang & Wen Tan. (2020) Comparison of the performance of inhalation nebulizer solution and suspension delivered with active and passive vibrating-mesh device. Journal of Drug Delivery Science and Technology 55, pages 101353.
Crossref
Crossref
Vicente Plaza, Jordi Giner, Elena Curto, M. Belén Alonso-Ortiz, Miren Itxaso Orue, José María Vega, Borja G. Cosío, Virginia Bellido Linares, Roberto Bernabeu Mora, Eva Cabrera Cesar, Ariel Callero Viera, Rafael Castillo, Julio Delgado Romero, Ma José Espinosa de los Monteros-Garde, José María Fernández Rodríguez-Lacín, José Carlos García Robaina, Aníbal Manuel Hernández Gil, José Miguel Hernández Rey, Guacimara Hernández Santana, Cristina López Ruiz, Enrique Mascaros Balaguer, Francisco Javier Mazo Echaniz, Núria Moreno Pérez, Antonio Parra Arrondo, José Portillo Sánchez, José Ramón Rodríguez Encinar, Elena Rodríguez Plata, Berta Román Bernal, Anna Sala Cunill, Fernando J. Sánchez Lora, Juan Miguel Sánchez Nieto, Joan Serra Batlles, José Joaquín Torres Relucio, Agustín Valido Morales, Rubén Luciano Vázquez Alarcón & José Luis Velasco Garrido. (2020) Determinants and Differences in Satisfaction with the Inhaler Among Patients with Asthma or COPD. The Journal of Allergy and Clinical Immunology: In Practice 8:2, pages 645-653.
Crossref
Crossref
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta & Mario Cazzola. (2020) Triple Combination Inhalers in Chronic Obstructive Pulmonary Disease and Asthma. US Respiratory & Pulmonary Diseases 5:1, pages 18.
Crossref
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R Celli. (2020) Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis. Chronic Respiratory Disease 17, pages 147997311990123.
Crossref
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R. Celli. (2020) Inhaler device feature preferences among patients with obstructive lung diseases. Medicine 99:25, pages e20718.
Crossref
Crossref
Donald A. Mahler. (2020) The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease. Respiratory Medicine 161, pages 105857.
Crossref
Crossref
Garner FaulknerIIII & Christopher J. Moore. 2020. Enhancing Patient Engagement in Pulmonary Healthcare. Enhancing Patient Engagement in Pulmonary Healthcare
243
264
.
Gustaf Ortsäter, Fredrik Borgström, Stéphane Soulard & Carolin Miltenburger. (2019) A Budget Impact Model to Estimate the Environmental Impact of Adopting RESPIMAT® Re-usable in the Nordics and Benelux. Advances in Therapy 36:12, pages 3435-3445.
Crossref
Crossref
Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather & Chris Compton. (2019) Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design. ERJ Open Research 5:4, pages 00061-2019.
Crossref
Crossref
Hannah A. Blair. (2019) Tiotropium/Olodaterol: A Review in COPD. Drugs 79:9, pages 997-1008.
Crossref
Crossref
Martyn F. Biddiscombe & Omar S. Usmani. (2018) Is there room for further innovation in inhaled therapy for airways disease?. Breathe 14:3, pages 216-224.
Crossref
Crossref
Jane Scullion. (2018) The Nurse Practitioners’ Perspective on Inhaler Education in Asthma and Chronic Obstructive Pulmonary Disease. Canadian Respiratory Journal 2018, pages 1-9.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD. The American Journal of Medicine 131:6, pages 608-622.
Crossref
Crossref
Alan Kaplan & David Price. (2018) Matching Inhaler Devices with Patients: The Role of the Primary Care Physician. Canadian Respiratory Journal 2018, pages 1-9.
Crossref
Crossref
Herbert Wachtel, Sabine Kattenbeck, Stephen Dunne & Bernd Disse. (2017) The Respimat® Development Story: Patient-Centered Innovation. Pulmonary Therapy 3:1, pages 19-30.
Crossref
Crossref